Heart Insight
Subscribe to Heart Insight e-news, our monthly publication delivering news, resources and stories for heart patients and their families.
Related Articles
Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
This Viewpoint discusses the health benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs); summarizes the clinical, policy, and equity implications of GLP-1 RA discontinuation; and…
Amazon’s AI lead says technical issues are holding back Alexa AI
Amazon has to overcome ‘several technical hurdles’ because it can roll out the new Alexa, according to The Financial Times.
3 Biden healthcare regulations Trump will have to finalize
Key rules on Medicare Advantage, telehealth and the No Surprises Act likely will be left for the Trump administration to finish.
This metaphorical cat is both dead and alive – and it will help quantum engineers detect computing errors
A team led by UNSW quantum engineers has created a “Schrödinger’s cat” – a famous quantum thought experiment – inside a silicon chip.
Octavia Butler imagined LA ravaged by fires. Her Altadena cemetery survived – WTOP News
ALTADENA, Calif. (AP) — Decades ago, the writer Octavia Butler had imagined a Los Angeles ravaged by fires. The Altadena cemetery where the science fiction…
The Big GenAI Time and Money Shift | PYMNTS.com
The average consumer spends about 3 seconds when opening an app on their smartphone. Most open 10 different apps a day. Over the course of…
Cross-sectional analysis of caesarean sections according to the Robson 10-group classification system in Somalia
Background Caesarean section (CS) is an important indicator of access to and quality of maternal health services. The WHO recommends the Robson 10-group classification system…
Germany Authorizes Military to Shoot Down Mysterious Drones
Germany is giving its armed forces the ability to shoot down unidentified drones suspected of spying on military bases, industrial facilities and other critical infrastructure,…
Will PBM reform save pharmacies from closing?
Policymakers are blaming PBMs for closures of pharmacies across the U.S. But the reality is more complicated.
First Evidence of Delayed Disability Progression in Nonrelapsing Secondary Progressive MS
For the first time, a drug has delayed disability progression in people with nonrelapsing secondary progressive multiple sclerosis.
